Clinical Trial Update: The Evaluation and Standardization of Ginseng and Its Components for Blood Pressure Regulation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the standardization of ginseng and its components for blood pressure regulation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Ginseng (Panax ginseng)

Snippet

Sponsor: Unity Health Toronto | Conditions: Hypertension | Phase 2 | Status: COMPLETED